Literature DB >> 25904244

Incremental prognostic value of the SYNTAX score to late gadolinium-enhanced magnetic resonance images for patients with stable coronary artery disease.

Shingo Kato1, Naka Saito2, Hidekuni Kirigaya2, Daiki Gyotoku2, Naoki Iinuma2, Yuka Kusakawa2, Kohei Iguchi2, Tatsuya Nakachi2, Kazuki Fukui2, Masaaki Futaki3, Tae Iwasawa3, Masataka Taguri4, Kazuo Kimura5, Satoshi Umemura6.   

Abstract

The prognostic significance of the SYNTAX (Synergy between PCI with Taxus and cardiac surgery) score has recently been demonstrated in patients with stable multivessel or left main coronary artery disease (CAD). The present study determines whether adding the SYNTAX score to Framingham risk score (FRS), left ventricular ejection fraction (LVEF) and presence of myocardial infarction (MI) by late gadolinium enhancement (LGE) magnetic resonance imaging can improve the risk stratification in patients with stable CAD. We calculated the SYNTAX score in 161 patients with stable CAD (mean age: 66 ± 10 years old). During a mean follow-up of 2.3 years, 56 (35 %) of 161 patients developed cardiovascular events defined as cardiovascular death, non-fatal MI, cerebral infarction, unstable angina pectoris, hospitalization due to heart failure and revascularization. Multivariate Cox regression analysis selected triglycerides [hazard ratio (HR): 1.005 (95 % confidence interval (CI): 1.001-1.008), p < 0.008], presence of LGE [HR: 6.329 (95 % CI: 2.662-15.05), p < 0.001] and the SYNTAX score [HR: 1.085 (95 % CI: 1.044-1.127), p < 0.001] as risk factors for future cardiovascular events. Adding the SYNTAX score to FRS, EF and LGE significantly improved the net reclassification index (NRI) [40.4 % (95 % CI: 18.1-54.8 %), p < 0.05] with an increase in C-statistics of 0.089 (from 0.707 to 0.796). An increase in C-statistics and significant improvement of NRI showed that adding the SYNTAX score to the FRS, LVEF and LGE incrementally improved risk stratification in patient with stable CAD.

Entities:  

Keywords:  Coronary artery disease; Late gadolinium enhancement; Magnetic resonance imaging; Prognosis; The SYNTAX score

Mesh:

Substances:

Year:  2015        PMID: 25904244     DOI: 10.1007/s00380-015-0685-x

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  31 in total

1.  Primary and subsequent coronary risk appraisal: new results from the Framingham study.

Authors:  R B D'Agostino; M W Russell; D M Huse; R C Ellison; H Silbershatz; P W Wilson; S C Hartz
Journal:  Am Heart J       Date:  2000-02       Impact factor: 4.749

2.  The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators.

Authors:  Paul A Scott; John M Morgan; Nicola Carroll; David C Murday; Paul R Roberts; Charles R Peebles; Stephen P Harden; Nick P Curzen
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-04-14

3.  Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease.

Authors:  Davide Capodanno; Maria Elena Di Salvo; Glauco Cincotta; Marco Miano; Claudia Tamburino; Corrado Tamburino
Journal:  Circ Cardiovasc Interv       Date:  2009-06-30       Impact factor: 6.546

4.  5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions.

Authors:  Patrick W Serruys; Yoshinobu Onuma; Scot Garg; Pascal Vranckx; Bernard De Bruyne; Marie-Claude Morice; Antonio Colombo; Carlos Macaya; Gert Richardt; Jean Fajadet; Christian Hamm; Monique Schuijer; Tessa Rademaker; Kristel Wittebols; Hans Peter Stoll
Journal:  J Am Coll Cardiol       Date:  2010-02-18       Impact factor: 24.094

5.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

6.  Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy.

Authors:  Oliver Bruder; Anja Wagner; Christoph J Jensen; Steffen Schneider; Peter Ong; Eva-Maria Kispert; Kai Nassenstein; Thomas Schlosser; Georg V Sabin; Udo Sechtem; Heiko Mahrholdt
Journal:  J Am Coll Cardiol       Date:  2010-06-25       Impact factor: 24.094

7.  Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo.

Authors:  Antonella Moreo; Giuseppe Ambrosio; Benedetta De Chiara; Min Pu; Tam Tran; Francesco Mauri; Subha V Raman
Journal:  Circ Cardiovasc Imaging       Date:  2009-09-03       Impact factor: 7.792

8.  Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction.

Authors:  Raymond Y Kwong; Hamid Sattar; Henry Wu; Gabriel Vorobiof; Vijay Gandla; Kevin Steel; Samuel Siu; Kenneth A Brown
Journal:  Circulation       Date:  2008-08-25       Impact factor: 29.690

9.  Baseline cardiac magnetic resonance imaging versus baseline endomyocardial biopsy for the prediction of left ventricular reverse remodeling and prognosis in response to therapy in patients with idiopathic dilated cardiomyopathy.

Authors:  Takeru Nabeta; Takayuki Inomata; Yuichiro Iida; Yuki Ikeda; Miwa Iwamoto; Shunsuke Ishii; Takanori Sato; Ichiro Watanabe; Takashi Naruke; Hisahito Shinagawa; Toshimi Koitabashi; Ichiro Takeuchi; Mototsugu Nishii; Yusuke Inoue; Tohru Izumi
Journal:  Heart Vessels       Date:  2013-10-04       Impact factor: 2.037

10.  Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis.

Authors:  Makoto Sano; Hiroshi Satoh; Kenichiro Suwa; Mamoru Nobuhara; Takeji Saitoh; Masao Saotome; Tsuyoshi Urushida; Hideki Katoh; Kumiko Shimoyama; Daisuke Suzuki; Noriyoshi Ogawa; Yasuo Takehara; Harumi Sakahara; Hideharu Hayashi
Journal:  Heart Vessels       Date:  2014-07-05       Impact factor: 2.037

View more
  2 in total

1.  Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients.

Authors:  Altaf Afrasyab; Peng Qu; Yang Zhao; Kuang Peng; Hongyan Wang; Dayuan Lou; Nan Niu; Dajun Yuan
Journal:  Heart Vessels       Date:  2015-08-20       Impact factor: 2.037

2.  Prediction of 1-year clinical outcomes using the SYNTAX score in patients with prior heart failure undergoing percutaneous coronary intervention: sub-analysis of the SHINANO registry.

Authors:  Masatoshi Minamisawa; Takashi Miura; Hirohiko Motoki; Hideki Kobayashi; Masanori Kobayashi; Hiroyuki Nakajima; Hikaru Kimura; Hiroshi Akanuma; Eiichiro Mawatari; Toshio Sato; Shoji Hotta; Yuichi Kamiyoshi; Takuya Maruyama; Noboru Watanabe; Takayuki Eisawa; Shinichi Aso; Shinichiro Uchikawa; Keisuke Senda; Takehiro Morita; Naoto Hashizume; Naoyuki Abe; Soichiro Ebisawa; Atsushi Izawa; Yusuke Miyashita; Jun Koyama; Uichi Ikeda
Journal:  Heart Vessels       Date:  2016-10-05       Impact factor: 2.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.